The core-binding factor β subunit is required for bone formation and hematopoietic maturation

Nature Genetics

Volumn 32, Issue 4, 2002, Pages 645-649

  Miller, Janelle ^a   Horner, Alan ^b   Stacy, Terryl ^a   Lowrey, Christopher ^a   Lian, Jane B ^c   Stein, Gary ^c   Nuckolls, Glen H ^b   Speck, Nancy A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR;

ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS; HEMATOPOIESIS; LYMPHOID CELL; LYMPHOPOIESIS; MORTALITY; MOUSE; MYELOPOIESIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CLONING, MOLECULAR; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; ENDOTHELIUM, VASCULAR; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, LETHAL; GENOTYPE; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LIVER; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 18744394030     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1049     Document Type: Article

References (29)

1. Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697-708 (1996).
2. Sasaki, K. et al. Absence of fetal liver hematopoiesis in transcriptional coactivator, core binding factor β (Cbfb) deficient mice. Proc. Natl Acad. Sci. USA 93, 12359-12363 (1996).
3. Jaffredo, T., Gautier, R., Eichmann, A. & Dieterlen-Lièvre, F. Intra-aortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 125, 4575-4583 (1998).
4. North, T.E. et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126, 2563-2575 (1999).
5. Yokomizo, T. et al. Requirement of Runx1/AML1/PEBP2αβ for the generation of haematopoietic cells from endothelial cells. Genes Cells 6, 13-23 (2001).
6. Sato, T.N. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74 (1995).
7. Schlaeger, T.M. et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl Acad. Sci. USA 94, 3058-3063 (1997).
8. Yano, M. et al. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood 89, 4317-4326 (1997).
9. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-772 (1997).
10. Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997).
11. Inada, M. et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214, 279-290 (1999).
12. Kim, I., Otto, F., Zabel, B. & Mundlos, S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159-170 (1999).
13. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
14. Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA 93, 3444-3449 (1996).
15. Li, Q.-L. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 (2002).
16. Levanon, D. et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21, 3454-3456 (2002).
17. Levanon, D. et al. Spatial and temporal expression pattern of Runx3 (Aml2) and Runxl (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech. Dev. 109, 413-417 (2001).
18. Hayashi, K. et al. Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage. J. Immunol. 167, 4957-4965 (2001).
19. Hayashi, K. et al. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J. Immunol. 165, 6816-6824 (2000).
20. Yoshida, C.A. et al. Core-binding factor β interacts with Runx2 and is required for skeletal development. Nature Genet. 32, 633-638 (2002).
21. Deguchi, K. et al. Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow. Biochem. Biophys. Res. Comm. 255, 352-359 (1999).
22. Castilla, L.H. et al. Chromosome 16 inversion-generated fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukemia. Nature Genet. 23, 144-146 (1999).
23. Kundu, M. et al. Cbfβ interacts with Runx2 and has a critical role in bone development. Nature Genet. 32, 639-644 (2002).
24. Tahirov, T.H. et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ. Cell 104, 755-767 (2001).
25. Nagata, T. & Werner, M.H. Functional mutagenesis of AML1/RUNX1 and PEBP2β/CBFβ define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain. J. Mol. Biol. 308, 191-203 (2001).
26. Mundlos, S. et al. Mutations involving the transcription factor CBFA1 cause Cleidocranial dysplasia. Cell 89, 773-780 (1997).
27. Zhou, G. et al. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8, 2311-2316 (1999).
28. Motoike, T. et al. Universal GFP reporter for the study of vascular development. Genesis 28, 75-81 (2000).
29. Rucklidge, G.J., Milne, G. & Robins, S.P. Collagen X: A component of the surface of normal human, pig, and rat articular cartilage. Biochem. Biophys. Res. Comm. 224, 297-302 (1996).